tetano
Editor, Senior Moderator
Nephron. 2020 Mar 23:1-9. doi: 10.1159/000507305. [Epub ahead of print]
Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.
Perico L[SUP]1[/SUP], Benigni A[SUP]1[/SUP], Remuzzi G[SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.
? 2020 S. Karger AG, Basel.
KEYWORDS:
Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; COVID-19; Renal and cardiac side effects; SARS-CoV-2; Severe acute respiratory syndrome coronavirus
PMID:32203970DOI:10.1159/000507305
Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.
Perico L[SUP]1[/SUP], Benigni A[SUP]1[/SUP], Remuzzi G[SUP]2,[/SUP][SUP]3[/SUP].
Author information
Abstract
Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.
? 2020 S. Karger AG, Basel.
KEYWORDS:
Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; COVID-19; Renal and cardiac side effects; SARS-CoV-2; Severe acute respiratory syndrome coronavirus
PMID:32203970DOI:10.1159/000507305